Clinical Trial Update: DILIPO (DILutIonal HyPOnatremia) [Phase 3]

View source ↗

Summary

A Sanofi-sponsored Phase 3 trial called DILIPO (DILutIonal HyPOnatremia) in congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Sanofi | Conditions: Congestive Heart Failure | Phase 3 | Status: COMPLETED